Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06596278
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-11
Brief Title:
Memesto Wearable Repetitive Message and Music Therapy Device Music Therapy Device That Senses and Reduces Agitation in People With AD
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Development of Memesto a Wearable Repetitive Message and Music Therapy Device That Senses and Reduces Agitation in Persons With ADADRD
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AWARD
Brief Summary:
This is a 12-week proof-of-concept study to evaluate the efficacy of Memesto in reducing agitation in persons with Alzheimers disease and Alzheimers disease related dementias ADADRD currently living in a residential care facility It is hypothesized that Memesto use will result in a reduction in agitation
Detailed Description:
After informed consent is obtained and preliminary eligibility established participants will be trained and issued the Memesto device for use over a 2-week screeningtraining phase Participants successfully completing this phase will proceed into a 10-week open label treatment phase via telephone andor in-person data collection
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None